These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 17322937

  • 1. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M, Cumpston AD, Hobbs GR, Devetten MP, Sarwari AR, Ericson SG.
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [Abstract] [Full Text] [Related]

  • 2. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A, Craig M, Hamadani M, Abraham J, Hobbs GR, Sarwari AR.
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [Abstract] [Full Text] [Related]

  • 3. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S, Kern WV, Sigge A, Döhner H, Marre R, Kern P, von Baum H.
    Clin Infect Dis; 2005 Apr 15; 40(8):1087-93. PubMed ID: 15791505
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A, Villasis-Keever A, Hernández-Bribiesca ME, Crespo-Solis E, Ruiz-Palacios GM, Sifuentes-Osornio J, Ponce-De-León-Garduño A.
    Rev Invest Clin; 2006 Apr 15; 58(6):547-54. PubMed ID: 17432285
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M, Morelli G, Mori S, Riccioni R, Papineschi F, Petrini M.
    Biomed Pharmacother; 2005 Oct 15; 59(9):511-6. PubMed ID: 16274955
    [Abstract] [Full Text] [Related]

  • 10. Moxifloxacin prophylaxis in neutropenic patients.
    von Baum H, Sigge A, Bommer M, Kern WV, Marre R, Döhner H, Kern P, Reuter S.
    J Antimicrob Chemother; 2006 Oct 15; 58(4):891-4. PubMed ID: 16880172
    [Abstract] [Full Text] [Related]

  • 11. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.
    Isr Med Assoc J; 2007 Jun 15; 9(6):424-9. PubMed ID: 17642387
    [Abstract] [Full Text] [Related]

  • 12. [Management of 315neutropenic febrile episodes in a cancer center].
    Dutronc H, Billhot M, Dupon M, Eghbali H, Donamaria C, Dauchy FA, Reiffers J.
    Med Mal Infect; 2009 Jun 15; 39(6):388-93. PubMed ID: 19062208
    [Abstract] [Full Text] [Related]

  • 13. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A, Swaroop C, Agarwala S, Pandey RM, Bakhshi S.
    J Pediatr Hematol Oncol; 2009 Sep 15; 31(9):635-41. PubMed ID: 19684522
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P, Baumgartner JD, Glauser MP, Cometta A.
    Schweiz Med Wochenschr; 2000 Dec 02; 130(48):1837-44. PubMed ID: 11132527
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
    Castagnola E, Faraci M.
    Expert Rev Anti Infect Ther; 2009 Jun 02; 7(5):607-21. PubMed ID: 19485800
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
    Eleutherakis-Papaiakovou E, Kostis E, Migkou M, Christoulas D, Terpos E, Gavriatopoulou M, Roussou M, Bournakis E, Kastritis E, Efstathiou E, Dimopoulos MA, Papadimitriou CA.
    Am J Hematol; 2010 Nov 02; 85(11):863-7. PubMed ID: 20882526
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
    Koya R, Andersen J, Fernandez H, Goodman M, Spector N, Smith R, Hanlon J, Cassileth PA.
    Bone Marrow Transplant; 1998 May 02; 21(9):923-6. PubMed ID: 9613785
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.